Abstract
New treatments for chondrosarcoma are extremely important. Chondrosarcoma is a primary malignant bone tumor with a very unfavorable prognosis. High-grade chondrosarcoma has a high potential to metastasize to any organ in the body. Platelet-derived growth factor (PDGF) is a potent angiogenic factor that promotes tumor angiogenesis and metastasis. The adipocytokine visfatin promotes metastatic potential of chondrosarcoma; however, the role of visfatin in angiogenesis in human chondrosarcoma is unclear. We report that the levels of PDGF-C expression were positively correlated with tumor stages, significantly higher than the levels of expression in normal cartilage. Visfatin increased PDGF-C expression and endothelial progenitor cell (EPC) angiogenesis through the PI3K/Akt/mTOR signaling pathway, and dose-dependently down-regulated the synthesis of miR-1264, which targets the 3′-UTR of PDGF-C. Additionally, we discovered inhibition of visfatin or PDGF-C in chondrosarcoma tumors significantly reduced tumor angiogenesis and size. Our results indicate that visfatin inhibits miR-1264 production through the PI3K/Akt/mTOR signaling cascade, and thereby promotes PDGF-C expression and chondrosarcoma angiogenesis. Visfatin may be worth targeting in the treatment of chondrosarcoma angiogenesis.
Funder
China Medical University
Ministry of Science and Technology
China Medical University Hospital
Reference62 articles.
1. Malignant bone tumors (other than ewing’s): Clinical practice guidelines for diagnosis, treatment and follow-up by spanish group for research on sarcomas (geis);Redondo;Cancer Chemother. Pharmacol.,2017
2. Chondrosarcoma: Biology, genetics, and epigenetics;Chow;F1000Research,2018
3. Chondrosarcoma;Weinschenk;J. Am. Acad. Orthop. Surg.,2021
4. Limaiem, F., Davis, D.D., and Sticco, K.L. Chondrosarcoma. Statpearls, 2022.
5. Biomarkers of chondrosarcoma;Jeong;J. Clin. Pathol.,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献